PDS-MMAE
Product Specifications
UNSPSC Description
PDS-MMAE (Compound 5’) is a modified MMAE (HY-15162). PDS-MMAE can be used for preparation of neurotensin receptor binding conjugates[1].
Target Antigen
Drug-Linker Conjugates for ADC
Type
ADC Related
Related Pathways
Antibody-drug Conjugate/ADC Related
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/pds-mmae.html
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
C[C@@H](C(N[C@H](C)[C@H](C1=CC=CC=C1)O)=O)[C@H]([C@@](CCC2)([H])N2C(C[C@@H](OC)[C@H]([C@@H](C)CC)N(C)C([C@H](C(C)C)NC([C@H](C(C)C)N(C)C(OCCSSC3=CC=CC=N3)=O)=O)=O)=O)OC
Molecular Weight
931.26
References & Citations
[1]Mark T. Bilodeau, et al. Neurotensin receptor binding conjugates and formulations thereof. Patent. WO2017180834.
Shipping Conditions
Room Temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-153958/PDS-MMAE-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-153958/PDS-MMAE-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
1613113-44-2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
QP8199-ec-500ug 500ug
Recombinant Human p53-regulated apoptosis-inducing protein 1, GST, E.coli-500ug
Ask
View Details 
